JP2009525970A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009525970A5 JP2009525970A5 JP2008552815A JP2008552815A JP2009525970A5 JP 2009525970 A5 JP2009525970 A5 JP 2009525970A5 JP 2008552815 A JP2008552815 A JP 2008552815A JP 2008552815 A JP2008552815 A JP 2008552815A JP 2009525970 A5 JP2009525970 A5 JP 2009525970A5
- Authority
- JP
- Japan
- Prior art keywords
- ono
- integer
- alkyl
- group
- branched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 125000002993 cycloalkylene group Chemical group 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 208000030533 eye disease Diseases 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 125000004434 sulfur atom Chemical group 0.000 claims 2
- 125000006832 (C1-C10) alkylene group Chemical group 0.000 claims 1
- 229940122072 Carbonic anhydrase inhibitor Drugs 0.000 claims 1
- 208000010412 Glaucoma Diseases 0.000 claims 1
- 206010030043 Ocular hypertension Diseases 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 239000002876 beta blocker Substances 0.000 claims 1
- 229940097320 beta blocking agent Drugs 0.000 claims 1
- 239000003489 carbonate dehydratase inhibitor Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 125000001893 nitrooxy group Chemical group [O-][N+](=O)O* 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Chemical group 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 239000011593 sulfur Chemical group 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
- 0 *Cc1cccc(CC(N2C(Nc3ccc4nccnc4c3Br)=NCC2)=O)c1 Chemical compound *Cc1cccc(CC(N2C(Nc3ccc4nccnc4c3Br)=NCC2)=O)c1 0.000 description 19
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76516606P | 2006-02-06 | 2006-02-06 | |
| PCT/EP2007/051017 WO2007090793A1 (en) | 2006-02-06 | 2007-02-02 | Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009525970A JP2009525970A (ja) | 2009-07-16 |
| JP2009525970A5 true JP2009525970A5 (enExample) | 2010-03-11 |
Family
ID=37810330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008552815A Withdrawn JP2009525970A (ja) | 2006-02-06 | 2007-02-02 | α２−アドレナリン受容体アゴニストとしてのアプラクロニジンおよびブリモドニジンのニトロオキシ含有誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7799784B2 (enExample) |
| EP (1) | EP1981852A1 (enExample) |
| JP (1) | JP2009525970A (enExample) |
| CA (1) | CA2641501A1 (enExample) |
| WO (1) | WO2007090793A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8062653B2 (en) | 2009-02-18 | 2011-11-22 | Bezwada Biomedical, Llc | Controlled release of nitric oxide and drugs from functionalized macromers and oligomers |
| EP2525793B1 (en) * | 2010-01-21 | 2018-09-05 | Allergan, Inc. | Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect |
| WO2013126156A1 (en) * | 2012-02-22 | 2013-08-29 | Bausch & Lomb Incorporated | Nitric oxide donating selective glucocorticoid receptor agonist compounds and ophthalmic compositions |
| CA2871292A1 (en) | 2012-05-31 | 2013-12-05 | Theravance Biopharma R&D Ip, Llc | Nitric oxide donor neprilysin inhibitors |
| WO2014144268A1 (en) * | 2013-03-15 | 2014-09-18 | University Of Maryland | Automated fruit and vegetable calyx or stem removal machine |
| WO2018175922A1 (en) | 2017-03-23 | 2018-09-27 | Graybug Vision, Inc. | Drugs and compositions for the treatment of ocular disorders |
| MX2019013363A (es) | 2017-05-10 | 2020-01-13 | Graybug Vision Inc | Microparticulas de liberacion extendida y suspensiones de las mismas para terapia medica. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4517199A (en) * | 1981-11-20 | 1985-05-14 | Alcon Laboratories, Inc. | Method for lowering intraocular pressure using phenylimino-imidazoles |
| US5856329A (en) | 1995-06-28 | 1999-01-05 | Allergan | Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| PL380065A1 (pl) * | 2003-12-02 | 2006-12-11 | Nicox S.A. | Nitrooksypochodne karwedilolu i inne beta blokery jako leki przeciwko nadciśnieniu |
| JP2007513113A (ja) | 2003-12-02 | 2007-05-24 | ニコックス エス エイ | 抗高血圧薬剤のニトロオキシ誘導体 |
-
2007
- 2007-02-02 US US12/162,529 patent/US7799784B2/en not_active Expired - Fee Related
- 2007-02-02 CA CA002641501A patent/CA2641501A1/en not_active Abandoned
- 2007-02-02 JP JP2008552815A patent/JP2009525970A/ja not_active Withdrawn
- 2007-02-02 WO PCT/EP2007/051017 patent/WO2007090793A1/en not_active Ceased
- 2007-02-02 EP EP07726294A patent/EP1981852A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009525970A5 (enExample) | ||
| TWI337994B (en) | Prostaglandin derivatives | |
| ES2782998T3 (es) | Análogos de oligonucleótidos que incorporan 5-aza-citosina en los mismos | |
| JP2022081661A5 (enExample) | ||
| JP2008525416A5 (enExample) | ||
| JP2009537550A5 (enExample) | ||
| JP2008526999A5 (enExample) | ||
| JP2009525302A5 (enExample) | ||
| RU2008119842A (ru) | Производные триазола в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы-1 | |
| JP2011519910A5 (enExample) | ||
| JP2013512277A5 (enExample) | ||
| RU2010116253A (ru) | Производные n-гидроксилсульфонамида как новые физиологически применимые доноры нитроксила | |
| RU2007124329A (ru) | ПРОИЗВОДНЫЕ 5-ГИДРОКСИБЕНЗОТИАЗОЛА В КАЧЕСТВЕ АГОНИСТОВ β2 АДРЕНОРЕЦЕПТОРОВ | |
| JP2012508249A5 (enExample) | ||
| JP2007532627A5 (enExample) | ||
| RU2003134629A (ru) | Соединения цефема | |
| JP2004523478A5 (enExample) | ||
| RU2009128970A (ru) | Производные изосорбидмононитрата для лечения кишечных заболеваний | |
| RU2002101622A (ru) | Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом | |
| JP2007534743A5 (enExample) | ||
| RU2011108485A (ru) | Новые (поли)аминоалкиламиноалкиламидные, алкилмочевинные или алкилсульфонамидные производные эпиподофиллотоксина, способ их получения и их применение в терапии в качестве противораковых средств | |
| JP2005536531A5 (enExample) | ||
| JP2005526138A5 (enExample) | ||
| RU2010154417A (ru) | Комбинация частичного агониста никотиновых рецепторов и ингибитора ацетилхолинетеразы, содержащая ее фармацетическая композиция, и ее применение в лечении когнитивных расстройств | |
| JP2009525970A (ja) | α２−アドレナリン受容体アゴニストとしてのアプラクロニジンおよびブリモドニジンのニトロオキシ含有誘導体 |